Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Deckers Outdoor Corp (DECK) vs Humana Inc (HUM) Price & Performance

Deckers Outdoor CorpTrade
Humana IncTrade

Price performance (Past 24H)

Key statistics

Deckers Outdoor Corp vs Humana Inc — how do they compare? Deckers Outdoor Corp trades at $83.04 (market cap $11.24B), while Humana Inc trades at $434.1 (market cap $46.49B). The key difference: Humana Inc is far larger — about 4.1× Deckers Outdoor Corp's market cap, and Humana Inc pays a 0.91% dividend while Deckers Outdoor Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Deckers Outdoor Corp for 71 Days and Humana Inc for 51 Days on average.

DECKHUM
Market Cap
$11.24B$46.49B
Volume
3,010,9452,567,704
Sector
Consumer CyclicalHealth
52-Week High
$120.94$409.85
52-Week Low
$77.51$163.67
Typical Hold Time
71 Days51 Days
Enterprise Value
$10.11B$53.84B
Dividend Yield
—0.91%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Deckers Outdoor Corp

Deckers Outdoor (DECK) trades at $83.32, up 3.66% with strong momentum as technical indicators show bullish signals. The company demonstrates robust fundamentals with revenue growing from $3.2B in 2022 to $5.0B in 2025, net profit margin expanding to 19.37%, and attractive valuation metrics including P/E of 11.74. Recent earnings beats and strong HOKA/UGG brand performance support positive sentiment.

Outlook remains positive with 44.65% analyst buy ratings and $117.13 consensus price target suggesting 40% upside potential. Key risks include competitive pressures in footwear sector and potential consumer spending slowdown. The stock presents a compelling growth opportunity with strong cash flow generation and expanding margins.

Humana Inc

Humana (HUM) trades at $436.00, up 9.96% in the last 24 hours, with a bullish technical signal and strong earnings beats in recent quarters. Revenue has grown to $129.66 billion in 2025, though net income margin compressed to 0.88%. Analyst consensus is a buy with a $457.05 price target, and recent news highlights a Barclays upgrade and dividend declaration.

The outlook is positive given earnings momentum and institutional interest, but risks include margin pressure and regulatory scrutiny. Upside potential exists if the company maintains enrollment growth and cost controls, though investors should monitor Medicare Advantage plan changes and competitive dynamics.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DECK
100% Buy0% Sell
Avg holding period · 71 Days
HUM
93% Buy7% Sell
Avg holding period · 51 Days

Top news

Latest headlines on both assets

About Deckers Outdoor Corp

Deckers Outdoor Corp designs and sells casual and performance footwear, apparel, and accessories. Primary brands include UGG, Teva, and Sanuk. The company distributes Most of its products through its wholesale business, but it also has a substantial direct-to-consumer business with its company-owned retail stores and websites. Most sales are in the United States, although the company also has retail stores and distributors throughout Europe, Asia, Canada, and Latin America. Deckers sources its products from independent manufacturers primarily in Asia.

Read more on DECK →

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM →